NeurAxis, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 2.46 million compared to USD 2.68 million a year ago. Net loss was USD 14.63 million compared to USD 4.78 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 USD | +0.36% |
|
-6.04% | +4.87% |
06-07 | NeurAxis Submits Application to FDA to Expand IB-Stim Label | MT |
05-22 | Earnings Flash (NRXS) NEURAXIS Posts Q1 Revenue $646,635 | MT |
![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.87% | 18.61M | |
+75.69% | 12.57B | |
+15.86% | 7.21B | |
-30.02% | 6.82B | |
+12.09% | 5.35B | |
+10.93% | 3.99B | |
-25.26% | 3.77B | |
-30.02% | 2.64B | |
+30.21% | 2.09B | |
-1.24% | 2.04B |
- Stock Market
- Equities
- NRXS Stock
- News NeurAxis, Inc.
- NeurAxis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023